Detection of PrPres in genetically susceptible fetuses from sheep with natural scrapie by Garza, M.C. et al.
Detection of PrPres in Genetically Susceptible Fetuses
from Sheep with Natural Scrapie
Marı´a Carmen Garza1, Natalia Ferna´ndez-Borges2, Rosa Bolea1, Juan Jose´ Badiola1, Joaquı´n Castilla2,3,
Eva Monleo´n1,4*
1Centro de Investigacio´n en Encefalopatı´as Espongiformes Transmisibles y Enfermedades Emergentes, Universidad de Zaragoza, Zaragoza, Spain, 2CIC bioGUNE, Parque
Tecnolo´gico de Bizkaia, Derio, Spain, 3 IKERBASQUE, Basque Foundation for Science, Bilbao, Spain, 4 Produccio´ Animal, Universitat de Lleida, LLeida, Spain
Abstract
Scrapie is a transmissible spongiform encephalopathy with a wide PrPres dissemination in many non-neural tissues and with
high levels of transmissibility within susceptible populations. Mechanisms of transmission are incompletely understood. It is
generally assumed that it is horizontally transmitted by direct contact between animals or indirectly through the
environment, where scrapie can remain infectious for years. In contrast, in utero vertical transmission has never been
demonstrated and has rarely been studied. Recently, the use of the protein misfolding cyclic amplification technique
(PMCA) has allowed prion detection in various tissues and excretions in which PrPres levels have been undetectable by
traditional assays. The main goal of this study was to detect PrPres in fetal tissues and the amniotic fluid from natural scrapie
infected ewes using the PMCA technique. Six fetuses from three infected pregnant ewes in an advanced clinical stage of the
disease were included in the study. From each fetus, amniotic fluid, brain, spleen, ileo-cecal valve and retropharyngeal
lymph node samples were collected and analyzed using Western blotting and PMCA. Although all samples were negative
using Western blotting, PrPres was detected after in vitro amplification. Our results represent the first time the biochemical
detection of prions in fetal tissues, suggesting that the in utero transmission of scrapie in natural infected sheep might be
possible.
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Introduction
Transmissible spongiform encephalopathies (TSEs) are fatal
neurodegenerative diseases that affect both humans and animals.
TSEs are characterized by long incubation periods, brain
vacuolation and the accumulation of an abnormal isoform (PrPres)
of a normal cellular protein (PrPc), mainly in nervous tissues. This
abnormal protein is considered the only reliable biochemical
disease marker [1]. Currently, most TSE diagnostic techniques are
based on the immunodetection of PrPres in extracts or tissue
sections of the central nervous system (CNS), mainly by Western
blotting (WB), immunohistochemistry (IHC) and enzyme-linked
immunosorbent assay (ELISA).
Scrapie is a TSE that affects sheep and goats. This disease is
associated with a wide PrPres dissemination in many non-neural
tissues, including the lymphoreticular system and the placenta
[2,3], and with high levels of transmissibility within susceptible
populations, although the mechanisms of transmission are not
completely understood. It is generally assumed that scrapie is
transmitted by direct contact between animals or indirectly
through the environment, where PrPres can exist for several years
[4,5]. In the case of scrapie in sheep, it is well known that the
delivery period and the placenta play a key role in the
transmission. Placentas from susceptible infected animals may
harbor a high amount of PrPres and high levels of infectivity [6]
when the fetus presents a susceptible PrP genotype [7,8,9].
In contrast, in utero transmission has never been clearly
demonstrated. Limited studies have not detected infectivity by
bioassay [10] or PrPres by conventional immunoassay of fetuses and
fetal fluids [7,8,11–13]. To our knowledge, only two experimental
studies suggest that in utero infection may occur [14,15].
Recently, the development of highly sensitive methodologies has
allowed the detection of PrPres in samples from infected scrapie
animals that are undetectable by traditional assays. Using the
protein misfolding cyclic amplification (PMCA) technique, PrPres
has been detected in milk, feces, urine, saliva and blood [16].
PMCA involves the in vitro amplification of PrPres using a normal
brain homogenate as the source of PrPc, leading to a several
million-fold increase in sensitivity compared to standard WB
assays [17]. The main goal of the present study was to attempt
detection of PrPres in fetal tissues and their amniotic fluid from
scrapie infected ewes using the PMCA technique.
Results
Detection of PrPres in dams by immunohistochemistry
A wide PrPres distribution was observed in the 3 ewes (Fig. 1).
In the CNS, the following areas showed detectable PrPres levels:
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the cervical, thoracic and lumbar spinal cord; obex; pons;
cerebellum; midbrain; diencephalon; pituitary; rhinencephalon;
basal ganglia; olfactory bulb; amygdale; optic chiasm; eye; and the
occipital, parietal and frontal cortex. All obex were scored as +++
(Fig. 1A). Regarding the lymphoreticular system (LRS), all tissues
examined were scored as ++ or +++ (Fig. 1B). In the case of the
palatine tonsil, retropharyngeal lymph node, spleen and lymphoid
tissue associated with the ileocecal valve, more than 50% of the
lymphoid follicles per section presented PrPres. In the case of
control lamb tissues, no PrPres was detected.
All the placentomes examined were PrPres positive. PrPres
deposition was multifocal along the transversal section of the
placentome and was located mainly at the level of the feto-
maternal interface. PrPres deposits were observed in endometrial
caruncular cells, trophoblast cells and hybrid syncytial plaques
(Fig. 1C, D).
All samples analyzed from the control lamb were negative using
IHC analysis.
Detection of PrPres in fetal tissues using Western blotting
The brain, spleen and amniotic fluid of all fetuses were negative
for PrPres using WB analysis.
Detection of PrPres in fetal tissues after serial automated
PMCA (saPMCA)
PrPres was detected in all fetuses after in vitro amplification
(Table 1). Fetus 1 was analyzed first. In this case, samples were
evaluated using WB after the 4th round of amplification, and those
tubes that showed PrPres amplification were analyzed at rounds 3,
2 and 1. After the 1st and 2nd round of 96 cycles of saPMCA,
none of the samples showed any detectable signal. After the 3rd
round, samples from the brain and the spleen (2 and 1 tubes,
respectively) showed a signal corresponding to amplified PrPres.
After a 4th round, a PrPres signal was observed in samples of each
kind (at least 1 tube of each tissue; Fig. 2). PrPres from a positive
control was successfully amplified through each round, whereas
none of the unseeded negative controls showed any detectable
signal.
Samples from the other 5 fetuses were evaluated using WB after
a 3rd and/or 4th round of amplification. As in the case of fetus 1,
the PrPres signal was observed in all samples (although not in all
fetuses). In these assays, positive controls were not included in the
saPMCA to prevent any source of contamination inside the
sonicator.
Samples from a negative lamb were analyzed to control
contamination during sample collection and initial processing.
After 4 rounds of amplification, no PrPres signal was observed in
any tissue sample.
Discussion
Scrapie is associated with high levels of transmissibility within
susceptible populations. Although it is generally accepted that the
natural spread of classical scrapie occurs mainly horizontally
[5,18], it is also known that there is an increased risk of developing
the disease in offspring from scrapie-infected ewes [19]. A recent
study has shown that this increased risk results not only from
genetic susceptibility but also because of the potential for the
infection to be transmitted from the dam to her offspring [20].
Until now, experimental studies have indicated that maternal
transmission occurs in the immediate postpartum period via milk
or contact with maternal contaminated tissues [18,21–23].Our
results suggest that in utero transmission can also be possible in
Figure 1. IHC detection of PrPres deposition in scrapie-infected dams. A wide PrPSc distribution was observed in the 3 scrapie-infected
dams. A high intensity of immunolabeling in an obex (A), a retropharyngeal lymph node (B) and a placentome at the level of feto-maternal interface
(C), is shown. In this image (D), the proximity between trophoblast cells presenting PrPSc deposits and a fetal vessel (*) can be observed.
doi:10.1371/journal.pone.0027525.g001
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natural scrapie-infected ewes. A previous study showed a vertical
transmission in a transgenic mouse line expressing bovine PrP
experimentally infected by intracerebral administration of BSE
prions [15]. In this study, blood was proposed as the vehicle for
prion spread due to its ability to retain prion infectivity [24].
However, there are differences with respect to the architectural
anatomies of mouse and ruminant placentation. In the mouse
placenta (hemotrichorial), all maternal tissue layers are removed
such that 3 trophoblast layers plus a fenestrated endothelium
separate the maternal and fetal blood. In the ruminant placenta
(synepitheliochorial), all maternal and fetal tissue layers are
present, although the uterine epithelium is greatly modified by
migration and fusion of the fetal binucleate trophoblast cells with
uterine epithelial cells. In this placenta type, contact between
maternal blood and trophoectoderm occurs mainly in the
hemophagous zones at the base of the fetal villi. In these zones,
trophoblast cells phagocytose maternal erythrocytes (as a source of
fetal iron), leukocytes and degenerated cells [25,26].
As it has been previously reported, we have observed that in
placentomes, PrPres accumulates mainly in trophoblast and
derivative syncytial cells [7,27]. However, it is unknown how
trophoblast cells acquire PrPres. One possible way could be
through phagocytosis of infected maternal blood in the hemoph-
agous zones [28]. PrPres could also be transcytosed in vesicular
structures across the fetal layers, forming complexes with other
proteins, such as ferritin, as has been described for the intestinal
epithelial barrier [29,30]. This mechanism could be favored by the
presence of many fetal capillaries in an ‘‘intraepithelial’’ position in
the trophoblast, thus reducing the placenta barrier [31] (Fig. 1D).
From fetal capillaries of the cotyledon, blood carrying PrPres could
reach the fetus by the umbilical cord. PrPc that is necessary for
prion replication [32] is expressed in ruminant embryos starting
day 4 post-fertilization [33]. Our results suggest that prions are
present at higher levels in the brain and the spleen of fetuses than
in other tissues (because they were detected by fewer PMCA
cycles). A high concentration of PrPc in the brain and the
accumulation of blood in the spleen could explain these results.
Previous studies have failed to detect PrPres in fetal tissues from
natural scrapie-infected ewes. However, in these studies, PrPres
detection is based on a conventional immunoassay [7,8,11–13]. In
the current study, the enhanced sensitivity of saPMCA allowed us
to detect amplifiable prions in fetal tissues from sheep with clinical
scrapie that presented a widespread PrPres deposition in the CNS
and lymphoid tissue. The use of the tg338 mouse line as a
substrate, which showed a higher sensitivity than other mouse lines
tested previously (data not shown), could also have contributed to
the sensitivity of the technique. The failure to detect PrPres in fetal
tissues with conventional assays suggests that prions are present at
very low levels. Previous studies have also amplified prions using
saPMCA in tissues, secretions or excretions that tested negative
when conventional assays were used [16,24,34,35]. saPMCA is a
highly sensitive technique that amplifies minute quantities of
Figure 2. WB detection of PrPres in tissues from fetus 1 after saPMCA. After the 4th round of saPMCA, at least one of the eight aliquots
analyzed from each tissue showed PrPSc amplification. None of the unseeded negative controls showed any detectable signal. NBH: Normal brain
homogenate without pK treatment. RLN: retropharyngeal lymph node. ICV: ileocecal valve.
doi:10.1371/journal.pone.0027525.g002
Table 1. PrPres amplification in fetal tissues after 3–4 rounds of saPMCA.
Fetus Fetal genotype Ewe
Month of
gestation PMCA Round Brain Spleen RLN ICV Amniotic Fluid
1 ARQ/ARQ A 5 3rd 2 1 0 0 0
4th 4 2 2 2 2
2* ARQ/AHQ B 4 4th 3 0 4 2 1
3* ARQ/ARQ B 4 4th 3 2 1 0 1
4 ARQ/ARQ B 4 3rd 1 2 0 0 0
5 ARQ/ARQ C 3 3rd 1 0 NT NT NT
4th NT NT 1 1 4
6 ARQ/ARQ C 3 4th 4 5 1 3 4
Number of positive aliquots for each sample analyzed (from a total of 8 aliquots).
RLN: retropharyngeal lymph node. ICV: ileocecal valve. NT: not tested.
*Fetuses 2 and 3 shared the same uterine horn.
doi:10.1371/journal.pone.0027525.t001
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PrPres [17]. However, it has been suggested that there is a risk of
obtaining false positive results when multiple rounds of PMCA are
performed, due either to contamination or spontaneous generation
[34]. Some authors [36] have shown that de novo generation of
prions does not occur under standard PMCA conditions and that
only when these conditions are modified can prions be generated
after 9 and 10 rounds of PMCA (in the case of hamsters and mice
samples, respectively). Using standard PMCA conditions, our
results show that prions can be detected in the fetal brain and
spleen after only three rounds of amplification. Although we
cannot discard completely a cross-contamination, specific precau-
tions (described in the material and methods) were taken to avoid
it during sample collection at necropsy and saPMCA procedure.
Our results represent the first time that prions have been
biochemically detected in fetal tissues, suggesting that in utero
transmission of scrapie could be possible. This vertical transmis-
sion could result from the large accumulation of maternal blood in
the placenta and subsequent feto-maternal interchange.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations for the care and use of experimental animals of
the University of Zaragoza, in accordance with law (R.D. 1201/
2005). The protocol was approved by its Committee on the Ethics
of Animal Experiments (Permit Number: PI02/08).
Animals and samples
Three pregnant Rasa aragonesa sheep (A, B and C; Table 1) were
selected from 3 different scrapie outbreaks detected in the
framework of the scrapie surveillance program. Animals were
selected on the basis of pregnancy, presenting an ARQ/ARQ
genotype, having a positive rectal biopsy and presenting severe
clinical signs. The signs observed were in accordance with previous
clinical characterizations of scrapie in this breed [37].
When clinical signs progressed to terminal, ewes were euthanized
by intravenous injections of sodium pentobarbital followed by
exsanguination. From each ewe, several neural and lymphoreticular
tissues and placentomes were sampled for PrPres detection using
IHC and amniotic fluid and fetuses were collected for WB and
saPMCA. At necropsy, the placenta was removed first, placed in a
clean area and processed with different materials to avoid
contamination from the infected dam. The amniotic fluid sample
was first collected with a sterile syringe by making a small incision to
separate the placental layers. After enlarging the incision, the fetus
was carefully separated from the placenta and immediately frozen at
280uC in an individual plastic bag until sampled in a laminar flow
cabinet in a different laboratory. From each ewe, the following
tissues were collected and immersed in 10% buffered formalin: the
spinal cord; cerebrum; cerebellum; palatine tonsils; spleen; ileocecal
valve; and the retropharyngeal, mediastinal, mesenteric, subman-
dibular, prescapular, iliac, precrural, popliteal and mammary
lymph nodes. Five placentomes were collected from each fetus.
To control for contamination during sample collection, a 2-
month-old ARQ/ARQ lamb from a negative flock was euthanised
and sampled after the last ewe (ewe C; the day after). In this case,
only the spleen and brain were collected in the necropsy room.
One section of each tissue was frozen at 280uC until used for
saPMCA, and another section was immersed in 10% buffered
formalin for PrPres detection using IHC. All animals included in
the present study were euthanised and sampled in the same
necropsy room at the University of Zaragoza and under the same
conditions. After each necropsy, all material and necropsy tables
were cleaned with sodium hypochlorite and decontaminated with
1 M NaOH overnight.
A total of 6 fetuses were included in the present study (Table 1).
Fetuses were sampled in a laminar flow cabinet at CIC bioGUNE
laboratory. From each fetus, samples from the brain, spleen,
ileocecal valve and retropharyngeal lymph node were collected. A
palatine tonsil from fetus 6 was also collected. The materials used
for sample collection was decontaminated between fetuses by
immersion in 1 M NaOH.
Immunohistochemistry
Samples from the ewes and the control lamb were analyzed
using IHC to detect PrPres and assess its distribution. Formalin-
fixed samples were trimmed and processed according to standard
histopathological procedures. The IHC protocol for PrPres
detection was performed as previously described [38]. Briefly, this
included immersion in 98% formic acid for 15 min followed by
proteinase K (F. Hoffmann La Roche Ltd, Switzerland; 4 mg/ml)
treatment for 15 min at 37u and hydrated autoclaving. Slides were
stained with an automated autostainer (Dako Denmark A/S,
Denmark). Anti-prion mAb L42 (R Biopharm Ltd., Germany;
1:500) was used as a primary antibody, followed by the application
of EnVision (Dako Denmark A/S, Denmark) as a visualization
system and diaminobenzidine (Dako Denmark A/S, Denmark) as
the chromogen. Sections were washed in distilled water and
counterstained with hematoxylin (Dako Denmark A/S, Denmark).
The PrPres signal was subjectively scored based on the extent of
immunostaining [39,40]. In the case of the medulla oblongata, +
was characterized by the accumulation of PrPres in the dorsal
motor nucleus of the vagus nerve, ++ was characterized by
accumulation of PrPres in the dorsal motor nucleus of the vagus
nerve and the adjacent nuclei, and +++ was characterized by
widespread PrPres in the whole section. In other areas of the CNS,
only the presence and absence of PrPres were assessed. In the case
of lymphoid tissue, + was characterized by ,10% of the lymphoid
follicles with PrPres deposits, ++ was defined as 10 to 50% of the
lymphoid follicles and +++ as .50% of the lymphoid follicles.
Western blotting
From each fetus, CNS, spleen and amniotic fluid were analyzed
using WB with PrionicsH-Check Western Small Ruminant
according to the manufacturer’s instruction with the exception
of the P4 mAb (R Biopharm Ltd., Germany; 1:5000).
saPMCA
Amniotic fluid and fetal tissues were analyzed by saPMCA as
described previously [41]. Briefly, brains from perfused (5 mM
EDTA in PBS) tg338 mice over-expressing the VRQ allele of ovine
PrP [42] were used as the substrate for in vitro prion conversion and
as unseeded negative controls. Mouse brain homogenates (10% w/
v) were prepared in a conversion buffer (PBS containing 150 mM
NaCl and 1% Triton X-100 with the addition of Complete Protease
Inhibitors; Roche Pharmaceuticals, Indianapolis, IN). Fetal tissue
samples were homogenized at a concentration of 10% (w/v) in
GIBCOH PBS (calcium and magnesium free) with Complete
Protease Inhibitors. Amniotic fluid was used without dilution in
PBS. In 0.2 ml PCR tubes, 5 ml of fetal tissue homogenate or
amniotic fluid was added to 50 ml of mice brain homogenate
(substrate). For each sample to be tested, 8 aliquots were analyzed.
Tubes were place on an adaptor on the plate holder of a
microsonicator (Misonix, USA, model S3000MP sonicator).
Unseeded substrates were used as negative controls. Substrates
seeded with scrapie-infected brains were used as positive controls.
Successive rounds of saPMCA consisting of 24 hours of cyclic
PrPres in Fetuses from Scrapie Infected Sheep
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amplification (incubation/sonication cycles) at 37uC were per-
formed for amplification. Incubations were done in water without
shaking. After each round, 10 ml of the amplified sample was diluted
into 50 ml of fresh substrate for serial amplification.
To detect the amplified product, samples were evaluated using
WB. One volume of amplified product was mixed with one volume
of a digestion buffer (PBS, 2% Tween and 2% NP-40) and digested
with proteinase K (85 mg/ml) for 60 min at 42uC with shaking
(450 rpm). Digestion was stopped by adding 10 ml SDS Nu-PAGE
loading buffer to all samples and incubating at 100uC for 10 min.
Proteins were resolved by SDS-PAGE (12% gel, Invitrogen life) and
transferred onto nitrocellulose membrane (GE Healthcare What-
man). Membranes were incubated for 1 h with P4 mAb (R
Biopharm Ltd., Germany) diluted 1:5000 in PBS with 0.05%
Tween-20 and 1% milk. The secondary antibody was goat anti-
mouse at 1:3000 dilution in PBS 0.05% Tween-20 with 1% milk.
After washing, immunoreactivity was detected using an enhanced
chemiluminescent substrate (Thermo Scientific SuperSignal West
Pico Chemiluminescent Substrate West Pico). Signals obtained by
Western blotting were analyzed using FluorChem Q system (Alpha
Innotech), and the data using AlphaView Q software.
Tissues from the control lamb were analyzed using saPMCA
under the same conditions as the fetal tissues.
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